Analysis of a population-based Pneumocystis carinii pneumonia Index as an outcome measure of access and quality of care for the treatment of HIV disease

American Journal of Public Health

Volumn 92, Issue 3, 2002, Pages 395-398

  Arno, Peter S ^a   Gourevitch, Marc N ^a   Drucker, Ernest ^a   Fang, Jing ^a   Goldberg, Clara ^a   Memmott, Margaret ^a   Bonuck, Karen ^a   Deb, Nandini ^a   Schoenbaum, Ellie ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PNEUMOCYSTIS PNEUMONIA; UNITED STATES;

EID: 0036184606     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.92.3.395     Document Type: Article

References (18)

1. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus
2. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus
3. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Disease specific recommendations
4. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
5. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: US Public Health Service and Infections Diseases Society of America
6. CDC surveillance summaries: April 16, 1999
7. The cost effectiveness of preventing AIDS-related opportunistic infections
8. Impact of opportunistic disease on survival in patients with HIV infection
9. Natural history of opportunistic disease in an HIV-infected urban clinical cohort
10. US hospital care for HIV-infected persons and the role of public, private and Veterans Administration hospitals
11. Pneumocystis carinii pneumonia in the protease inhibitor era
12. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study
13. Geographic distribution of human immunodeficiency virus-associated Pneumocystis carinii pneumonia in San Francisco
14. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection
15. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy
16. Effect on HAART on natural history of AIDS-related opportunistic disorders
17. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres
18. HIV infection in hospitalized patients and Medicaid enrollees: The accuracy of medical recording coding